• Premium
  • About
  • Partner Pages
  • Support & FAQs
  • Log in
The Mandarin
The Mandarin
  • Premium
  • Careers
    • Search SES Jobs
    • Career Advice
  • News
  • Editors’ Picks
  • Portfolios
  • Events
  • Resource library
  • Small Logo
  • Premium
  • Careers
    • Search SES Jobs
    • Career Advice
  • News
  • Editors’ Picks
  • Portfolios
  • Events
  • Resource library

MSD


 logo

For more than a century, MSD has been inventing medicines and vaccines for many of the world’s most challenging diseases.


Latest Articles

New models key to getting better access to new pan-tumour drugs
Partner Content

New models key to getting better access to new pan-tumour drugs

December 11, 2018

By Amanda Dickerson

How can Australia usher in the new wave of immunotherapy cancer treatments?
Partner Content

How can Australia usher in the new wave of immunotherapy cancer treatments?

October 31, 2018

By The Mandarin

Immunotherapy cancer treatments: the European perspective
Partner Content

Immunotherapy cancer treatments: the European perspective

October 10, 2018

By Nerissa Bentley

Beating cancer: the public policy challenge
Partner Content

Beating cancer: the public policy challenge

December 11, 2017

By Tom Burton

  • Features
Winning the 5000 year fight against cancer
Partner Content

Winning the 5000 year fight against cancer

October 9, 2017

By Tom Burton

  • Features
Pharma research play translates into jobs and growth
Partner Content

Pharma research play translates into jobs and growth

August 7, 2017

By Tom Burton

  • Features
What will it take to make Australia a global pharma player?
Partner Content

What will it take to make Australia a global pharma player?

June 7, 2017

By Tom Burton

  • Economy & Industry

Career Advice

Browse Career Advice articles

In to bat again for Julian Assange

In to bat again for Julian Assange

May 20, 2024

By Laurie Patton

  • Editors' Picks
The endless quest for transparency and accountability
  • Premium
  • Case studies

The endless quest for transparency and accountability

May 17, 2024

By Tom Ravlic

  • Editors' Picks
Public sector estimates’ homework should be more detailed

Public sector estimates’ homework should be more detailed

May 17, 2024

By Tom Ravlic

  • Defence
Lobbyists feed into political bias which feeds into distrust of government
  • Premium
  • Columnists

Lobbyists feed into political bias which feeds into distrust of government

May 15, 2024

By Richard Mulgan

  • Editors' Picks
Everything you need to know about what the budget means for the bureaucracy
  • Premium
  • Insights and analysis

Everything you need to know about what the budget means for the bureaucracy

May 14, 2024

By Stephen Bartos

  • Economy & Industry
Budget 2024: APS payroll headcount surges to 300,000

Budget 2024: APS payroll headcount surges to 300,000

May 14, 2024

By Julian Bajkowski

  • Economy & Industry
Browse Career Advice articles

Login

Get Premium now. Not ready? Get the free Daily newsletter.

Forgot password?

Share via email

The Mandarin

The Mandarin is an essential resource for anyone interested in Australia's public sector, with daily news, commentary, analysis and expert advice.

Follow The Mandarin
Acknowledgement of Country

The Mandarin acknowledges the Traditional Owners of the many nations across Australia, and pay our respect to Elders past and present. We recognise that their sovereignty has never been ceded.

Content
  • News
  • Research Series
  • Features
  • Portfolios
  • Jurisdictions
  • New Zealand
  • People & Capability
  • Thought Leadership
  • Editors’ Picks
  • Resource Library
  • Site Map
Products & Services
  • Mandarin Premium
  • Mandarin Careers
  • Mandarin Live
  • The Juice Newsletter
  • Partner & Advertising solutions
  • Public Sector Events Calendar
  • Partner Content
Legal
  • Privacy Policy
  • Terms of Usage
  • Code of Conduct
Connect
  • About Us
  • Contact Us
  • Support
  • Our Team
Copyright © 2024 Private Media Pty Ltd. Publishers of TheMandarin.com.au. All Rights Reserved
Crikey SmartCompany Inc. Australia Private Media